The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,170,360 in first-year total cost, median $393,500.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-9 (O1)]3
Most frequent institutions
- MAYO CLINIC ROCHESTER1
- STANFORD UNIVERSITY1
- UNIVERSITY OF MICHIGAN AT ANN ARBOR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Single-cell epigenomics and transcriptomics of diabetic gastroparesis in humans1R01DK131455-01 | BHARUCHA, ADIL E.ORDOG, TAMAS | MAYO CLINIC ROCHESTER, MN | $397,500 | ZDK1 |
| 2021 | From stomach tissue to cellular mechanisms: unraveling the role of mononuclear phagocytes in the pathophysiology of gastroparesis1R01DK131500-01 | IDOYAGA, JULIANA | STANFORD UNIVERSITY, CA | $393,500 | ZDK1 |
| 2021 | Use of novel MRI technology to study pathophysiology diabetic gastroparesis1R01DK131524-01 | CHEN, JIANDELIU, ZHONGMINGOWYANG, CHUNG | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $379,360 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.